Avid Bioservices Inc (CDMO)

[jazzbeerman]

moby,


-


IMO an important difference in the two trials is that in the Avastin trial
21 of the 27 patients had had NO PRIOR CHEMO FOR MBC



As for numbers-

there were 27 patients in the Avastin trial.

0 had a complete response
14 were classified with a partial response
9 were classified with stable disease
2 had progressive disease
2 dropped out

Patients had already started progressing at 2 months


There have (so far) been 14 patients in the Bavituximab trial.

7 have been classified with a partial response
7 have been classified with stable disease.

none of the treated patients have progressed at 2 months,
and none of the patients out 4 months have progressed.








j